An evaluation of short-term outcomes after reoperations for anastomotic leakage in colon cancer patients

por Warps, A. K., Dekker, J. W. T., Tanis, P. J., Tollenaar, R. A. E. M.
Publicado 2021

Chemotherapy resistance and stromal targets in breast cancer treatment: a review

por van der Spek, Y. M., Kroep, J. R., Tollenaar, R. A. E. M., Mesker, Wilma E.
Publicado 2020

A 10-Year Evaluation of Short-Term Outcomes After Synchronous Colorectal Cancer Surgery: a Dutch Population-Based Study

por Warps, A. K., Detering, R., Dekker, J. W. T., Tollenaar, R. A. E. M., Tanis, P. J.
Publicado 2021

PO-1472 OnCovid!: a project to ensure continuity and adequate quality of oncological care during the COVID-19 pandemic

por Verheij, M., Aziz, L., van Duijvendijk, P., Filipe, M., Goes, N., van Kooten, R., Makineli, S., Tollenaar, R., Witkamp, A.
Publicado 2021

Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients

por Bock, G H de, Tollenaar, R A E M, Papelard, H, Cornelisse, C J, Devilee, P, Vijver, M J van de
Publicado 2001

Impact of transanal endoscopic microsurgery on functional outcome and quality of life

por Doornebosch, P. G., Gosselink, M. P., Neijenhuis, P. A., Schouten, W. R., Tollenaar, R. A. E. M., de Graaf, E. J. R.
Publicado 2008

Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients

por Papelard, H, de Bock, G H, van Eijk, R, Vlieland, T P M Vliet, Cornelisse, C J, Devilee, P, Tollenaar, R A E M
Publicado 2000

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review

por Kramer, C. J. H., Vangangelt, K. M. H., van Pelt, G. W., Dekker, T. J. A., Tollenaar, R. A. E. M., Mesker, W. E.
Publicado 2018

Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.

por Kuppen, P. J., Jonges, L. E., van de Velde, C. J., Vahrmeijer, A. L., Tollenaar, R. A., Borel Rinkes, I. H., Eggermont, A. M.
Publicado 1997

Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the...

por Heeg, E., Jensen, M. B., Mureau, M. A. M., Ejlertsen, B., Tollenaar, R. A. E. M., Christiansen, P. M., Vrancken Peeters, M. T. F. D.
Publicado 2020

Antibodies against p53 are associated with poor prognosis of colorectal cancer.

por Houbiers, J. G., van der Burg, S. H., van de Watering, L. M., Tollenaar, R. A., Brand, A., van de Velde, C. J., Melief, C. J.
Publicado 1995

Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment

por van Dijk, S, Otten, W, Zoeteweij, M W, Timmermans, D R M, van Asperen, C J, Breuning, M H, Tollenaar, R A E M, Kievit, J
Publicado 2003

Importance of the First Postoperative Year in the Prognosis of Elderly Colorectal Cancer Patients

por Dekker, J. W. T., van den Broek, C. B. M., Bastiaannet, E., van de Geest, L. G. M., Tollenaar, R. A. E. M., Liefers, G. J.
Publicado 2011

Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD stu...

por Vogelaar, F. J., van Pelt, G. W., van Leeuwen, A. M., Willems, J. M., Tollenaar, R. A. E. M., Liefers, G. J., Mesker, W. E.
Publicado 2016

National differences in implementation of minimally invasive surgery for colorectal cancer and the influence on short-term outcomes

por Warps, A. K., Saraste, D., Westerterp, M., Detering, R., Sjövall, A., Martling, A., Dekker, J. W. T., Tollenaar, R. A. E. M., Matthiessen, P., Tanis, P. J.
Publicado 2022

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer

por Mesker, W E, Dekker, T J A, de Kruijf, E M, Engels, C C, van Pelt, G W, Smit, V T H B M, Tollenaar, R A E M
Publicado 2015

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.

por Tollenaar, R. A., van Krieken, J. H., van Slooten, H. J., Bruinvels, D. J., Nelemans, K. M., van den Broek, L. J., Hermans, J., van Dierendonck, J. H.
Publicado 1998

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

por van Sprundel, T C, Schmidt, M K, Rookus, M A, Brohet, R, van Asperen, C J, Rutgers, E J Th, van‘t Veer, L J, Tollenaar, R A E M
Publicado 2005

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations

por van Pelt, G. W., Kjær-Frifeldt, S., van Krieken, J. H. J. M., Al Dieri, R., Morreau, H., Tollenaar, R. A. E. M., Sørensen, F. B., Mesker, W. E.
Publicado 2018

Interhospital referral of colorectal cancer patients: a Dutch population-based study

por Warps, A. K., de Neree tot Babberich, M. P. M., Dekker, E., Wouters, M. W. J. M., Dekker, J. W. T., Tollenaar, R. A. E. M., Tanis, P. J.
Publicado 2021